Intermediate-term performance and safety of His-bundle pacing leads: A single-center experience

The short-term safety, feasibility, and performance of His-bundle pacing (HBP) leads have been reported; however, their longer-term performance beyond 1 year remains unclear. The purpose of this study was to examine the intermediate-term performance and safety of HBP. All HBP lead implants at Virginia Commonwealth University between January 2014 and January 2019 were analyzed. HBP was performed using a Medtronic SelectSecure 3830-69 cm pacing lead. Of 295 attempts, successful HBP implantation (selective or nonselective) was seen in 274 cases (93%). Mean follow-up duration was 22.8 ± 19.5 months (median 19.5; interquartile range 11–33). Mean age was 69 ± 15 years; 58% were males; and ejection fraction